SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,000,009 | -11.8% | 3,460,208 | 0.0% | 2.70% | +21.4% |
Q2 2023 | $90,726,654 | +1.9% | 3,460,208 | 0.0% | 2.22% | -22.5% |
Q1 2023 | $89,065,754 | -1.0% | 3,460,208 | 0.0% | 2.87% | +4.7% |
Q4 2022 | $90,000,010 | -8.8% | 3,460,208 | 0.0% | 2.74% | -6.0% |
Q3 2022 | $98,720,000 | +436.7% | 3,460,208 | +961.8% | 2.91% | +406.8% |
Q1 2022 | $18,393,000 | – | 325,881 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |